论文部分内容阅读
支气管哮喘是严重威胁人体健康的常见病之一,治疗不当易并发呼吸衰竭及心力衰竭,甚至发生死亡。25％硫酸镁静脉滴注治疗支气管哮喘持续状态36例,与对照组(氨茶碱治疗组)36例相比较,效果较满意。报告如下。 1 资料与方法 1.1 一般资料:本组病例系笔者在综合医院工作期间于住院病人中随机选择72例支气管哮喘病人进行分组观察用药。男52例,女20例,年龄最小1岁,最大60岁。1～10岁26例,11～20岁20例,20岁以上26例。72例均为支气管哮喘持续状态且
Bronchial asthma is one of the common diseases that seriously threaten human health. If improper treatment is used, respiratory failure, heart failure and even death may occur. Thirty-six cases of bronchial asthma were treated by intravenous infusion of 25% magnesium sulfate, compared with 36 cases in the control group (aminophylline-treated group). The results were satisfactory. The report is as follows. 1 Materials and Methods 1.1 General Information: In this group of cases, the author in the general hospital during the period of 72 patients with bronchial asthma randomized in-patient observation group medication. 52 males and 20 females, the youngest 1 year old, maximum 60 years old. 1 ~ 10 years old in 26 cases, 11 ~ 20 years old in 20 cases, 26 cases over the age of 20. 72 cases were bronchial asthma persistence and